Alliance News

US Health Landscape Remains Unsettled Amid Agency Turmoil, Foreign Aid Reorientation, and Public Health Preparedness Concerns

May 14, 2026

Recent weeks have brought continued turbulence across US health agencies, including the resignation of FDA Commissioner Marty Makary amid internal conflicts. Vaccine policy, vacancies in CDC and FDA leadership, NIH funding levels, USAID dismantling, and withheld support for international initiatives such as Gavi and HIV programs continue to cause concern. The past several weeks have also seen growing alarm from researchers, lawmakers, and public health officials about scientific independence and the administration’s handling of infectious disease preparedness amid the hantavirus outbreak. Against this backdrop, the State Department announced $1.8 billion in new US humanitarian aid aligned with the Trump administration’s foreign policy interests, and the Supreme Court ruled that Mifepristone may remain available by mail nationwide while litigation continues.

Resources

Advocacy and Mobilization

Navigating the Legal Questions and Resources for Workers

Tracking Impact

 

Sources

May 14, 2026

May 13, 2026

May 12, 2026

May 11, 2026

May 9, 2026

May 8, 2026

May 7, 2026

May 6, 2026

May 5, 2026

May 4, 2026

May 3, 2026

April 30, 2026

April 29, 2026

April 28, 2026

April 27, 2026

April 26, 2026

April 25, 2026

April 24, 2026

April 23, 2026

April 22, 2026

April 21, 2026

April 19, 2026

April 17, 2026

April 16, 2026

April 15, 2026

April 14, 2026

April 13, 2026

April 12, 2026

April 9, 2026

April 8, 2026

April 5, 2026

April 3, 2026

April 2, 2026

April 1, 2026